Correction: Consensus statement on standards and guidelines for the molecular diagnostics of Alport syndrome: refining the ACMG criteria(European Journal of Human Genetics, (2021), 29, 8, (1186-1197), 10.1038/s41431-021-00858-1)
Savige, Judy; Storey, Helen; Watson, Elizabeth; Hertz, Jens Michael; Deltas, Constantinos; Renieri, Alessandra; Mari, Francesca; Hilbert, Pascale; Plevova, Pavlina; Byers, Peter; Cerkauskaite, Agne; Gregory, Martin; Cerkauskiene, Rimante; Ljubanovic, Danica Galesic; Becherucci, Francesca; Errichiello, Carmela; Massella, Laura; Aiello, Valeria; Lennon, Rachel; Hopkinson, Louise; Koziell, Ania; Lungu, Adrian; Rothe, Hansjorg Martin; Hoefele, Julia; Zacchia, Miriam; Martic, Tamara Nikuseva; Gupta, Asheeta; van Eerde, Albertien; Gear, Susie; Landini, Samuela; Palazzo, Viviana; al-Rabadi, Laith; Claes, Kathleen; Corveleyn, Anniek; Van Hoof, Evelien; van Geel, Micheel; Williams, Maggie; Ashton, Emma; Belge, Hendica; Ars, Elisabeth; Bierzynska, Agnieszka; Gangemi, Concetta; Lipska-Ziętkiewicz, Beata S.
(2024) European Journal of Human Genetics, volume 32, issue 1
(Comment)
Abstract
Correction to: European Journal of Human Genetics (2021) 29:1186–1197 The following Acknowledgement was missing: This research has been supported not financially by “European Reference Network for Rare Kidney Disease, ERKNet”. This ERN is partly co-funded by the European Union within the framework of the Third Health Programme “ERN- 2016 –
... read more
Framework Partnership Agreement 2017–2021”. The original article has been corrected.
show less
Download/Full Text
Keywords: Genetics, Genetics(clinical)
ISSN: 1018-4813
Publisher: Nature Publishing Group
Note: Funding Information: This research has been supported not financially by “European Reference Network for Rare Kidney Disease, ERKNet”. This ERN is partly co-funded by the European Union within the framework of the Third Health Programme “ERN- 2016 – Framework Partnership Agreement 2017–2021”. Publisher Copyright: © 2023 The Author(s).
(Peer reviewed)